Fundraising Fox

Patrick Heron

Investor

Managing Partner at Frazier Life Sciences · Managing Partner at Frazier Healthcare Partners

Palo Alto

FoundedArcutis BiotherapeuticsCidara TherapeuticsCollegium PharmaceuticalImago BioSciences, Inc.Iterum TherapeuticsNexcida Therapeutics

About

Patrick Heron co-leads Frazier's Life Sciences team and is a Managing Partner and co-founder of that team, having joined the firm in 1999 and opened its Palo Alto office in 2003. He invests across therapeutics, from early-stage drug development to commercial-stage pharmaceutical companies. Before Frazier, he helped build McKinsey & Company's West Coast biotechnology consulting practice, and he holds an M.B.A. from Harvard Business School and a B.A. from the University of North Carolina at Chapel Hill.

Invests in

Biotech

Experience

  1. Frazier Life SciencesManaging Partnercurrent1999 — presentPalo Alto, California, United States
  2. Alpha-9 OncologyBoard Chaircurrent2022 — presentBoston, Massachusetts, United States
  3. Mirum PharmaceuticalsBoard Membercurrent2018 — presentSan Francisco Bay Area
  4. Alceptor TherapeuticsBoard Membercurrent2020 — present
  5. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)Board Membercurrent2016 — present
  6. MBX Biosciences, Inc.Board Membercurrent2020 — presentIndianapolis, Indiana, United States
  7. BlueWater Biosciences, IncBoard Membercurrent2024 — present
  8. Aspen Neuroscience, Inc.Board Observercurrent2020 — presentSan Diego, California, United States
  9. Gates FoundationInvestment Committee Member - Strategic Investment Fundcurrent2020 — presentSeattle, Washington, United States
  10. Tubulis GmbHBoard Member2025 — 2026Munich, Bavaria, Germany
  11. HilleVaxBoard Member2021 — 2025Boston, Massachusetts, United States
  12. SanReno TherapeuticsBoard Member2022 — 2023Shanghai, China
  13. Scout BioChairman of the Board2018 — 2023Greater Philadelphia
  14. IMAGO BIOSCIENCES LTDBoard Member2014 — 2022San Francisco Bay Area
  15. VaxcyteBoard Member2017 — 2021Redwood City
  16. Passage BioBoard Member2018 — 2021Greater Philadelphia
  17. Iterum Therapeutics LimitedBoard Member2015 — 2021Dublin, Ireland
  18. AmunixBoard Member2019 — 2021San Francisco Bay Area
  19. Zavante Therapeutics, Inc.Board Member2016 — 2018San Diego, California
  20. Silvergate PharmaceuticalsBoard Member2011 — 2018Denver, CO

Education

  1. Harvard Business SchoolMBA1994 — 1996
  2. The University of North Carolina at Chapel HillBA, Political Science1988 — 1992

Skills & more

Private Equity17Mergers2ValuationVenture Capital19Strategic Partnerships1Mergers & Acquisitions8Start-ups12Due Diligence6Biotechnology2Corporate Development11Investments2Venture Financing2
+8 moreHealthcareInvestor RelationsEntrepreneurshipFinancial ModelingGrowth CapitalAngel InvestingLife SciencesStrategy

From Patrick's professional profile.

Same school

Shared employers

Deals · 19

MBX BiosciencesBoard seat

via Frazier Life Sciences · filed Nov 2022 · $115.2M raise

SutroVaxBoard seat

via Frazier Life Sciences · filed Apr 2020 · $110M raise

Iterum Therapeutics BermudaBoard seat

via Frazier Life Sciences · filed Jan 2020 · $51.6M raise

Arcutis BiotherapeuticsBoard seat

via Frazier Life Sciences · filed Oct 2019 · $94.5M raise

Passage BioBoard seat

via Frazier Life Sciences · filed Sep 2019 · $110M raise

Mirum PharmaceuticalsBoard seat

via Frazier Life Sciences · filed Nov 2018 · $120.1M raise

Recida TherapeuticsBoard seat

via Frazier Life Sciences · filed Jul 2018 · $10.7M raise

Imago BioSciences, Inc.Board seat

via Frazier Life Sciences · filed Feb 2017 · $40.5M raise

SG PharmaceuticalsBoard seat

via Frazier Life Sciences · filed Apr 2016 · $45.7M raise

Silvergate PharmaceuticalsBoard seat

via Frazier Life Sciences · filed Oct 2015 · $4.6M raise

Nexcida TherapeuticsBoard seat

via Frazier Life Sciences · filed Jun 2015 · $21.3M raise

Collegium PharmaceuticalBoard seat

via Frazier Life Sciences · filed Mar 2015 · $50M raise

Cidara TherapeuticsBoard seat

via Frazier Life Sciences · filed Feb 2015 · $42M raise

IgnytaLed round

via Frazier Life Sciences · filed Nov 2015

CalixaLed round

via Frazier Life Sciences

CerexaLed round

via Frazier Life Sciences

CollegiumLed round

via Frazier Life Sciences

MarcadiaLed round

via Frazier Life Sciences

PreCision DermatologyLed round

via Frazier Life Sciences

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Frazier Life Sciences

Network1

Investors connected to Patrick in public investor directories — a warm-intro map.